Brief: Clearmind Medicine Inc - Dsmb Approves Continuation Of Phase I/Iia Cmnd-100 Trial In AUD
March 4 (Reuters) - Clearmind Medicine Inc CMND.O: CLEARMIND MEDICINE INC - DSMB APPROVES CONTINUATION OF PHASE I/IIA CMND-100 TRIAL IN AUD Source text: ID:nGNX4cf6yg Further company coverage: CMND.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM